ArticleJCO clinical cancer informatics2017

Chart review versus an automated bioinformatic approach to assess real-world crizotinib effectiveness in ALK-positive NSCLC.

Nam Bui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.